SRNE
Sorrento Therapeutics Inc
Price:  
0.31 
USD
Volume:  
176,993,280.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRNE WACC - Weighted Average Cost of Capital

The WACC of Sorrento Therapeutics Inc (SRNE) is 8.0%.

The Cost of Equity of Sorrento Therapeutics Inc (SRNE) is 8.60%.
The Cost of Debt of Sorrento Therapeutics Inc (SRNE) is 5.50%.

Range Selected
Cost of equity 7.30% - 9.90% 8.60%
Tax rate 0.60% - 2.00% 1.30%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.7% - 9.3% 8.0%
WACC

SRNE WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.63 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.90%
Tax rate 0.60% 2.00%
Debt/Equity ratio 0.24 0.24
Cost of debt 4.00% 7.00%
After-tax WACC 6.7% 9.3%
Selected WACC 8.0%